116 related articles for article (PubMed ID: 14508232)
1. Novel anticoagulant activity of polyamino acid offsets bacterial endotoxin-induced extrinsic hypercoagulation: downregulation of monocytic tissue factor-dependent FVII activation.
Chu AJ; Rauci M; Nwobi OI; Mathews ST; Beydoun S
J Cardiovasc Pharmacol; 2003 Oct; 42(4):477-83. PubMed ID: 14508232
[TBL] [Abstract][Full Text] [Related]
2. Novel anticoagulant activity of polybrene: inhibition of monocytic tissue factor hypercoagulation following bacterial endotoxin induction.
Chu AJ; Rauci M; Nwobi OI; Mathews ST; Beydoun S
Blood Coagul Fibrinolysis; 2002 Mar; 13(2):123-8. PubMed ID: 11914654
[TBL] [Abstract][Full Text] [Related]
3. Protamine inhibits tissue factor-initiated extrinsic coagulation.
Chu AJ; Wang ZG; Raicu M; Beydoun S; Ramos N
Br J Haematol; 2001 Nov; 115(2):392-9. PubMed ID: 11703341
[TBL] [Abstract][Full Text] [Related]
4. Possible role of Marcks in the cellular modulation of monocytic tissue factor-initiated hypercoagulation.
Chu AJ; Lin SH; Piasentin E
Br J Haematol; 2002 Aug; 118(2):569-76. PubMed ID: 12139748
[TBL] [Abstract][Full Text] [Related]
5. III. Instantaneous inhibition by compound 48/80 of tissue factor-initiated extrinsic coagulation is mediated by the downregulation of factor VII activation.
Chu AJ; Wang ZG; Fox MJ
Arch Biochem Biophys; 2000 May; 377(2):357-65. PubMed ID: 10845714
[TBL] [Abstract][Full Text] [Related]
6. Novel anticoagulant polyethylenimine: inhibition of thrombin-catalyzed fibrin formation.
Chu AJ; Beydoun S; Mathews ST; Hoang J
Arch Biochem Biophys; 2003 Jul; 415(1):101-8. PubMed ID: 12801518
[TBL] [Abstract][Full Text] [Related]
7. Compound 48/80 suppresses monocytic tissue factor-initiated extrinsic blood coagulation induced by bacterial endotoxin.
Chu AJ; Raphael UO; Prasad JK; Beydoun S; Ramos N
J Surg Res; 1999 Dec; 87(2):252-7. PubMed ID: 10600357
[TBL] [Abstract][Full Text] [Related]
8. IV. Anticoagulant activity of compound 48/80: inhibition of factor VII activation in leukemia THP-1 monocytes.
Chu AJ; Wang ZG; Raphael UO
J Cardiovasc Pharmacol; 2000 Nov; 36(5):649-55. PubMed ID: 11065226
[TBL] [Abstract][Full Text] [Related]
9. Antimicrobial peptide buforin I inhibits tissue factor-initiated coagulation.
Chu AJ; Chen BM; Lin H; Beydoun S
Arch Biochem Biophys; 2001 Aug; 392(1):3-7. PubMed ID: 11469787
[TBL] [Abstract][Full Text] [Related]
10. Blockade by ruthenium red of tissue factor-initiated coagulation.
Chu AJ; Wang ZG; Nwobi OI; Beydoun S
Br J Pharmacol; 2001 Jul; 133(5):659-64. PubMed ID: 11429389
[TBL] [Abstract][Full Text] [Related]
11. Polycations selectively blocking tissue factor-dependent FVII activation: collective in vitro anticoagulation studies.
Chu AJ
Inflamm Allergy Drug Targets; 2011 Feb; 10(1):13-8. PubMed ID: 21184651
[TBL] [Abstract][Full Text] [Related]
12. Anticoagulant potential of an antibody against factor VII.
Chu AJ; Mathews ST
J Surg Res; 2003 Sep; 114(1):37-41. PubMed ID: 13678696
[TBL] [Abstract][Full Text] [Related]
13. I. Suppression by compound 48/80 of bacterial endotoxin-inducible monocytic tissue factor activity: direct blockade of factor VII binding to THP-1 monocytes.
Chu AJ; Walton MA; Seto A; Fox MJ; Prasad JK; Wang ZG
Biochim Biophys Acta; 1999 Oct; 1472(1-2):385-94. PubMed ID: 10572960
[TBL] [Abstract][Full Text] [Related]
14. Involvement of MAPK activation in bacterial endotoxin-inducible tissue factor upregulation in human monocytic THP-1 cells.
Chu AJ; Wang ZG; Walton MA; Seto A
J Surg Res; 2001 Nov; 101(1):85-90. PubMed ID: 11676560
[TBL] [Abstract][Full Text] [Related]
15. Antagonism by IL-4 and IL-10 of endotoxin-induced tissue factor activation in monocytic THP-1 cells: activating role of CD14 ligation.
Chu AJ; Prasad JK
J Surg Res; 1998 Nov; 80(1):80-7. PubMed ID: 9790819
[TBL] [Abstract][Full Text] [Related]
16. [Inactivated factor VII exercises a powerful antithrombotic activity in an experimental model of recurrent arterial thrombosis].
Ragni M; Golino P; Cirillo P; Pascucci I; Scognamiglio A; Ravera A; Esposito N; Battaglia C; Guarino A; Chiariello M
Cardiologia; 1996 Jan; 41(1):51-8. PubMed ID: 8697470
[TBL] [Abstract][Full Text] [Related]
17. A cyclic pentapeptide derived from the second EGF-like domain of Factor VII is an inhibitor of tissue factor dependent coagulation and thrombus formation.
Orning L; Fischer PM; Hu CK; Agner E; Engebretsen M; Husbyn M; Petersen LB; Orvim U; Llinas M; Sakariassen KS
Thromb Haemost; 2002 Jan; 87(1):13-21. PubMed ID: 11848442
[TBL] [Abstract][Full Text] [Related]
18. Tissue factor upregulation drives a thrombosis-inflammation circuit in relation to cardiovascular complications.
Chu AJ
Cell Biochem Funct; 2006; 24(2):173-92. PubMed ID: 15617024
[TBL] [Abstract][Full Text] [Related]
19. Endotoxin-binding synthetic peptides with endotoxin-neutralizing, antibacterial and anticoagulant activities.
Hirata M; Shimomura Y; Yoshida M; Wright SC; Larrick JW
Prog Clin Biol Res; 1994; 388():147-59. PubMed ID: 7831355
[TBL] [Abstract][Full Text] [Related]
20. Synthetic peptide analogs of tissue factor and factor VII which inhibit factor Xa formation by the tissue factor/factor VIIa complex.
Rønning HF; Risøen UC; Orning L; Sletten K; Sakariassen KS
Thromb Res; 1996 Oct; 84(2):73-81. PubMed ID: 8897697
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
